

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.92663781 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.92663781 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.74257925 |
| 4 | definitive hemopoiesis (GO:0060216) | 3.99701252 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93649341 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.88507841 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 3.59057714 |
| 8 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.58826286 |
| 9 | cellular extravasation (GO:0045123) | 3.50882044 |
| 10 | positive regulation of granulocyte differentiation (GO:0030854) | 3.48299911 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 3.46360252 |
| 12 | NIK/NF-kappaB signaling (GO:0038061) | 3.44775281 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 3.43230824 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 3.42711280 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.39792916 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.39792916 |
| 17 | embryonic process involved in female pregnancy (GO:0060136) | 3.38552566 |
| 18 | regulation of integrin activation (GO:0033623) | 3.38132414 |
| 19 | detection of other organism (GO:0098543) | 3.37286734 |
| 20 | germinal center formation (GO:0002467) | 3.34770741 |
| 21 | regulation of mast cell degranulation (GO:0043304) | 3.34395328 |
| 22 | detection of bacterium (GO:0016045) | 3.30011817 |
| 23 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.28387824 |
| 24 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.25261983 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.25261983 |
| 26 | cellular response to zinc ion (GO:0071294) | 3.24497593 |
| 27 | regulation of mast cell activation (GO:0033003) | 3.18403147 |
| 28 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18324233 |
| 29 | response to host immune response (GO:0052572) | 3.18112884 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.18112884 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15954613 |
| 32 | immunoglobulin mediated immune response (GO:0016064) | 3.14599727 |
| 33 | regulation of B cell apoptotic process (GO:0002902) | 3.13214692 |
| 34 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.12397638 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.11914477 |
| 36 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10413884 |
| 37 | positive regulation of mast cell activation (GO:0033005) | 3.09614274 |
| 38 | T-helper 1 type immune response (GO:0042088) | 3.08283756 |
| 39 | response to interferon-beta (GO:0035456) | 3.07162213 |
| 40 | mature B cell differentiation involved in immune response (GO:0002313) | 3.05165633 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00472139 |
| 42 | negative thymic T cell selection (GO:0045060) | 2.99267460 |
| 43 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.97962190 |
| 44 | positive regulation of mast cell degranulation (GO:0043306) | 2.97962190 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 2.97579740 |
| 46 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.96720725 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96674249 |
| 48 | response to host (GO:0075136) | 2.96674249 |
| 49 | response to host defenses (GO:0052200) | 2.96674249 |
| 50 | myeloid dendritic cell activation (GO:0001773) | 2.95932859 |
| 51 | regulation of B cell differentiation (GO:0045577) | 2.94792943 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 2.91988153 |
| 53 | microglial cell activation (GO:0001774) | 2.91839823 |
| 54 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88465937 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 2.87350514 |
| 56 | cellular response to exogenous dsRNA (GO:0071360) | 2.87199388 |
| 57 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.86617949 |
| 58 | response to peptidoglycan (GO:0032494) | 2.85012345 |
| 59 | regulation of germinal center formation (GO:0002634) | 2.84782533 |
| 60 | positive thymic T cell selection (GO:0045059) | 2.84309050 |
| 61 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.84116596 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 2.83524376 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 2.83233604 |
| 64 | B cell mediated immunity (GO:0019724) | 2.82791562 |
| 65 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.82381480 |
| 66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82255957 |
| 67 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.82055592 |
| 68 | detection of external biotic stimulus (GO:0098581) | 2.81613610 |
| 69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81067029 |
| 70 | negative T cell selection (GO:0043383) | 2.80773388 |
| 71 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.80206778 |
| 72 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80024128 |
| 73 | response to interferon-alpha (GO:0035455) | 2.79329173 |
| 74 | histamine secretion (GO:0001821) | 2.77488662 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76997056 |
| 76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.75989699 |
| 77 | megakaryocyte development (GO:0035855) | 2.75761005 |
| 78 | regulation of natural killer cell differentiation (GO:0032823) | 2.75467560 |
| 79 | thrombin receptor signaling pathway (GO:0070493) | 2.75166111 |
| 80 | T cell migration (GO:0072678) | 2.74538476 |
| 81 | response to type I interferon (GO:0034340) | 2.74347271 |
| 82 | replication fork processing (GO:0031297) | 2.73888888 |
| 83 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.72641898 |
| 84 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.72500070 |
| 85 | regulation of T-helper cell differentiation (GO:0045622) | 2.70768812 |
| 86 | cellular response to type I interferon (GO:0071357) | 2.70686526 |
| 87 | type I interferon signaling pathway (GO:0060337) | 2.70686526 |
| 88 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.68731779 |
| 89 | tolerance induction (GO:0002507) | 2.68604264 |
| 90 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.68283847 |
| 91 | mature B cell differentiation (GO:0002335) | 2.68205115 |
| 92 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.67492672 |
| 93 | dosage compensation (GO:0007549) | 2.66695653 |
| 94 | positive regulation of antigen processing and presentation (GO:0002579) | 2.66629864 |
| 95 | macrophage activation (GO:0042116) | 2.66622187 |
| 96 | myeloid dendritic cell differentiation (GO:0043011) | 2.66524804 |
| 97 | cellular response to interferon-gamma (GO:0071346) | 2.66469080 |
| 98 | hepatocyte apoptotic process (GO:0097284) | 2.66398252 |
| 99 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.66048950 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 2.65838802 |
| 101 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.65562549 |
| 102 | response to protozoan (GO:0001562) | 2.65402996 |
| 103 | DNA deamination (GO:0045006) | 2.61519946 |
| 104 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.61025397 |
| 105 | viral transcription (GO:0019083) | 2.59031213 |
| 106 | regulation of erythrocyte differentiation (GO:0045646) | 2.56570585 |
| 107 | positive regulation of interferon-alpha production (GO:0032727) | 2.56101038 |
| 108 | DNA topological change (GO:0006265) | 2.54857903 |
| 109 | telomere maintenance via recombination (GO:0000722) | 2.54495721 |
| 110 | execution phase of apoptosis (GO:0097194) | 2.54089831 |
| 111 | neutrophil activation involved in immune response (GO:0002283) | 2.53618248 |
| 112 | negative regulation of granulocyte differentiation (GO:0030853) | 2.53554327 |
| 113 | DNA strand elongation (GO:0022616) | 2.51301013 |
| 114 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.49323900 |
| 115 | DNA unwinding involved in DNA replication (GO:0006268) | 2.48991961 |
| 116 | cellular response to interferon-beta (GO:0035458) | 2.48749636 |
| 117 | defense response to protozoan (GO:0042832) | 2.48301579 |
| 118 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.46078212 |
| 119 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.45902942 |
| 120 | translational termination (GO:0006415) | 2.45302921 |
| 121 | negative regulation of viral genome replication (GO:0045071) | 2.44426008 |
| 122 | regulation of necroptotic process (GO:0060544) | 2.43805666 |
| 123 | positive regulation of protein homooligomerization (GO:0032464) | 2.43322334 |
| 124 | T cell homeostasis (GO:0043029) | 2.42673713 |
| 125 | regulation of interferon-alpha production (GO:0032647) | 2.42045989 |
| 126 | meiotic chromosome segregation (GO:0045132) | 2.40598436 |
| 127 | dendritic cell differentiation (GO:0097028) | 2.39514662 |
| 128 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.37721718 |
| 129 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.37721718 |
| 130 | modulation by symbiont of host immune response (GO:0052553) | 2.37721718 |
| 131 | positive regulation by symbiont of host defense response (GO:0052509) | 2.37721718 |
| 132 | modulation by symbiont of host defense response (GO:0052031) | 2.37721718 |
| 133 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.37721718 |
| 134 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.32667832 |
| 135 | negative regulation by host of viral transcription (GO:0043922) | 2.32007562 |
| 136 | T cell apoptotic process (GO:0070231) | 2.31765022 |
| 137 | positive regulation of interferon-beta production (GO:0032728) | 2.31084340 |
| 138 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.31015688 |
| 139 | mitotic recombination (GO:0006312) | 2.30726561 |
| 140 | neutrophil activation (GO:0042119) | 2.30488148 |
| 141 | leukocyte aggregation (GO:0070486) | 2.28976307 |
| 142 | proline biosynthetic process (GO:0006561) | 2.27796547 |
| 143 | regulation of antigen processing and presentation (GO:0002577) | 2.27149170 |
| 144 | positive regulation of natural killer cell activation (GO:0032816) | 2.26744572 |
| 145 | regulation of RIG-I signaling pathway (GO:0039535) | 2.25944055 |
| 146 | negative regulation of RNA splicing (GO:0033119) | 2.25730410 |
| 147 | natural killer cell differentiation (GO:0001779) | 2.24804833 |
| 148 | leukocyte cell-cell adhesion (GO:0007159) | 2.23871923 |
| 149 | formation of translation preinitiation complex (GO:0001731) | 2.21634105 |
| 150 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.21391465 |
| 151 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.21384572 |
| 152 | angiogenesis involved in wound healing (GO:0060055) | 2.20761068 |
| 153 | granulocyte activation (GO:0036230) | 2.20299694 |
| 154 | cytokine secretion (GO:0050663) | 2.19078960 |
| 155 | actin nucleation (GO:0045010) | 2.18067576 |
| 156 | lymphocyte homeostasis (GO:0002260) | 2.17625418 |
| 157 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.17469631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.49970327 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.00637154 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.76806881 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.28531607 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.00025422 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.99638525 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.93820544 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80294123 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.79196969 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.77598202 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.75035712 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62391453 |
| 13 | * MYC_22102868_ChIP-Seq_BL_Human | 2.49720725 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44296113 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.40396658 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39626901 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.39000249 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35136828 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.31565282 |
| 20 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.28463221 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16251997 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12477729 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09424300 |
| 24 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.07445653 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06288535 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02500523 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.99392406 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98828165 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95984486 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.94198167 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91147649 |
| 32 | * MAF_26560356_Chip-Seq_TH1_Human | 1.90588155 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85700812 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.85019065 |
| 35 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84567706 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84359055 |
| 37 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83365204 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82845105 |
| 39 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.81558666 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.80247945 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78940416 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74860658 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74452330 |
| 44 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70912911 |
| 45 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69941750 |
| 46 | * MYB_26560356_Chip-Seq_TH1_Human | 1.69453603 |
| 47 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59240291 |
| 48 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.54875449 |
| 49 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51265755 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44790565 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41546611 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41203717 |
| 53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.40086575 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39892903 |
| 55 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37981656 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37163366 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35841391 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34488615 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33804248 |
| 60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.31353530 |
| 61 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31019909 |
| 62 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.26827600 |
| 63 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26395952 |
| 64 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26148287 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25081819 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24442670 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24070518 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22006233 |
| 69 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21630753 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.21108858 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20541882 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20335552 |
| 73 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20198494 |
| 74 | GATA2_19941826_ChIP-Seq_K562_Human | 1.20071956 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19691073 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19387320 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18013499 |
| 78 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16819780 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13018543 |
| 80 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.08890867 |
| 81 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08466998 |
| 82 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07215424 |
| 83 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.06718098 |
| 84 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06172614 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02858429 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01997859 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00184975 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98282558 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97988783 |
| 90 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97751469 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97732424 |
| 92 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97563231 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97406595 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97384214 |
| 95 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96200108 |
| 96 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96141715 |
| 97 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96022537 |
| 98 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.95087612 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94632596 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94538822 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94375380 |
| 102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94181105 |
| 103 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93206413 |
| 104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92011202 |
| 105 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.91988886 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90832124 |
| 107 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.88984521 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87535400 |
| 109 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.86694561 |
| 110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86511981 |
| 111 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86369193 |
| 112 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84493615 |
| 113 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.84351966 |
| 114 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.84088377 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82683423 |
| 116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.79220485 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77199443 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76465979 |
| 119 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.74882972 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74515431 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73389344 |
| 122 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.73322607 |
| 123 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72945781 |
| 124 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72618837 |
| 125 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71796837 |
| 126 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71497864 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70551531 |
| 128 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67093172 |
| 129 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64494341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.38830269 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.27558988 |
| 3 | MP0000685_abnormal_immune_system | 2.94358344 |
| 4 | MP0008057_abnormal_DNA_replication | 2.66082448 |
| 5 | MP0003436_decreased_susceptibility_to | 2.46948108 |
| 6 | MP0009785_altered_susceptibility_to | 2.39952736 |
| 7 | * MP0009278_abnormal_bone_marrow | 2.39451352 |
| 8 | * MP0005397_hematopoietic_system_phenotyp | 2.37036971 |
| 9 | * MP0001545_abnormal_hematopoietic_system | 2.37036971 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.33349471 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.23842210 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.21733107 |
| 13 | MP0005025_abnormal_response_to | 2.18846254 |
| 14 | * MP0004808_abnormal_hematopoietic_stem | 2.18200134 |
| 15 | MP0005174_abnormal_tail_pigmentation | 2.11495001 |
| 16 | MP0005671_abnormal_response_to | 2.10439360 |
| 17 | MP0001800_abnormal_humoral_immune | 2.08576907 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.07819191 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.04992824 |
| 20 | MP0001790_abnormal_immune_system | 2.04232868 |
| 21 | MP0005387_immune_system_phenotype | 2.04232868 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.03218795 |
| 23 | MP0002419_abnormal_innate_immunity | 2.00070986 |
| 24 | MP0002006_tumorigenesis | 1.97265505 |
| 25 | * MP0002398_abnormal_bone_marrow | 1.90264260 |
| 26 | MP0002723_abnormal_immune_serum | 1.89652398 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.87284416 |
| 28 | MP0001819_abnormal_immune_cell | 1.86672300 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.86612954 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.85468562 |
| 31 | * MP0010155_abnormal_intestine_physiology | 1.84112157 |
| 32 | MP0002405_respiratory_system_inflammati | 1.83572455 |
| 33 | MP0001853_heart_inflammation | 1.81722510 |
| 34 | MP0003303_peritoneal_inflammation | 1.80918778 |
| 35 | MP0000490_abnormal_crypts_of | 1.78934179 |
| 36 | MP0001873_stomach_inflammation | 1.76429948 |
| 37 | MP0003724_increased_susceptibility_to | 1.67192607 |
| 38 | * MP0000716_abnormal_immune_system | 1.66618490 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.65938781 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.62456161 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.61695145 |
| 42 | MP0010094_abnormal_chromosome_stability | 1.60523833 |
| 43 | MP0002722_abnormal_immune_system | 1.59808684 |
| 44 | MP0002009_preneoplasia | 1.55900955 |
| 45 | MP0006082_CNS_inflammation | 1.52737974 |
| 46 | * MP0002429_abnormal_blood_cell | 1.49507678 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.48738879 |
| 48 | MP0004947_skin_inflammation | 1.43453898 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.40803209 |
| 50 | MP0004510_myositis | 1.39475544 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.39308251 |
| 52 | MP0003693_abnormal_embryo_hatching | 1.38969778 |
| 53 | MP0010307_abnormal_tumor_latency | 1.36197993 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.30864691 |
| 55 | MP0003448_altered_tumor_morphology | 1.30217329 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.30195167 |
| 57 | MP0003866_abnormal_defecation | 1.27861867 |
| 58 | MP0002254_reproductive_system_inflammat | 1.27071208 |
| 59 | MP0008004_abnormal_stomach_pH | 1.25713946 |
| 60 | MP0003077_abnormal_cell_cycle | 1.25137112 |
| 61 | MP0005310_abnormal_salivary_gland | 1.24849082 |
| 62 | MP0008007_abnormal_cellular_replicative | 1.23296404 |
| 63 | MP0003075_altered_response_to | 1.21273065 |
| 64 | MP0001851_eye_inflammation | 1.21153252 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.20796119 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.19708575 |
| 67 | MP0000858_altered_metastatic_potential | 1.17597818 |
| 68 | * MP0002019_abnormal_tumor_incidence | 1.14244568 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.13061141 |
| 70 | MP0003828_pulmonary_edema | 1.11336676 |
| 71 | MP0001533_abnormal_skeleton_physiology | 1.11244149 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.09384022 |
| 73 | MP0003943_abnormal_hepatobiliary_system | 1.09120620 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 1.07304989 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.05931022 |
| 76 | MP0005166_decreased_susceptibility_to | 1.05356467 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 1.04576376 |
| 78 | MP0008469_abnormal_protein_level | 1.04437864 |
| 79 | MP0005058_abnormal_lysosome_morphology | 1.01168046 |
| 80 | MP0003111_abnormal_nucleus_morphology | 1.01111093 |
| 81 | MP0000343_altered_response_to | 0.99659354 |
| 82 | MP0000371_diluted_coat_color | 0.96177731 |
| 83 | MP0004957_abnormal_blastocyst_morpholog | 0.95362779 |
| 84 | MP0008058_abnormal_DNA_repair | 0.94522377 |
| 85 | MP0005023_abnormal_wound_healing | 0.91307892 |
| 86 | MP0003195_calcinosis | 0.91127233 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.90745649 |
| 88 | MP0000350_abnormal_cell_proliferation | 0.88988091 |
| 89 | MP0000313_abnormal_cell_death | 0.87614473 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.87433390 |
| 91 | MP0005164_abnormal_response_to | 0.83682634 |
| 92 | MP0000569_abnormal_digit_pigmentation | 0.81811027 |
| 93 | MP0009764_decreased_sensitivity_to | 0.79145762 |
| 94 | MP0002132_abnormal_respiratory_system | 0.77936972 |
| 95 | MP0006054_spinal_hemorrhage | 0.77377053 |
| 96 | MP0009840_abnormal_foam_cell | 0.77124031 |
| 97 | MP0002933_joint_inflammation | 0.76407571 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.74616754 |
| 99 | * MP0002086_abnormal_extraembryonic_tissu | 0.74518308 |
| 100 | MP0000249_abnormal_blood_vessel | 0.73857893 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.72642927 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.72419110 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72163694 |
| 104 | MP0005670_abnormal_white_adipose | 0.72067065 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.70494707 |
| 106 | MP0004883_abnormal_blood_vessel | 0.69610683 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.69428704 |
| 108 | MP0008260_abnormal_autophagy | 0.69411147 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.68672387 |
| 110 | MP0002277_abnormal_respiratory_mucosa | 0.67899270 |
| 111 | MP0005390_skeleton_phenotype | 0.66708068 |
| 112 | MP0005165_increased_susceptibility_to | 0.66439877 |
| 113 | MP0001915_intracranial_hemorrhage | 0.66358932 |
| 114 | MP0003795_abnormal_bone_structure | 0.65072977 |
| 115 | MP0005451_abnormal_body_composition | 0.64708743 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.64215096 |
| 117 | MP0001663_abnormal_digestive_system | 0.63715418 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.63416846 |
| 119 | MP0000470_abnormal_stomach_morphology | 0.63005055 |
| 120 | MP0004381_abnormal_hair_follicle | 0.61948047 |
| 121 | MP0000598_abnormal_liver_morphology | 0.61203222 |
| 122 | MP0009115_abnormal_fat_cell | 0.60790424 |
| 123 | MP0009763_increased_sensitivity_to | 0.59379638 |
| 124 | MP0005535_abnormal_body_temperature | 0.58350961 |
| 125 | MP0003045_fibrosis | 0.56816796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.20035685 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.14555123 |
| 3 | Myositis (HP:0100614) | 4.06931418 |
| 4 | Thrombocytosis (HP:0001894) | 4.05821495 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.04253375 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.92338389 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.78523917 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.67877947 |
| 9 | Pustule (HP:0200039) | 3.57941036 |
| 10 | Autoimmune hemolytic anemia (HP:0001890) | 3.56071677 |
| 11 | Recurrent viral infections (HP:0004429) | 3.45008372 |
| 12 | Agammaglobulinemia (HP:0004432) | 3.42438646 |
| 13 | Chronic otitis media (HP:0000389) | 3.39046605 |
| 14 | Orchitis (HP:0100796) | 3.35389205 |
| 15 | IgM deficiency (HP:0002850) | 3.25645878 |
| 16 | Prolonged bleeding time (HP:0003010) | 3.12215974 |
| 17 | Petechiae (HP:0000967) | 3.11322898 |
| 18 | Optic neuritis (HP:0100653) | 3.10764034 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.10764034 |
| 20 | Abnormality of T cell physiology (HP:0011840) | 3.09041649 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.04262525 |
| 22 | Cellulitis (HP:0100658) | 2.99797700 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 2.98777766 |
| 24 | Abnormality of B cell number (HP:0010975) | 2.91709191 |
| 25 | IgA deficiency (HP:0002720) | 2.86009693 |
| 26 | Increased IgM level (HP:0003496) | 2.83570917 |
| 27 | Poikiloderma (HP:0001029) | 2.81331294 |
| 28 | Albinism (HP:0001022) | 2.74726221 |
| 29 | Recurrent skin infections (HP:0001581) | 2.71844524 |
| 30 | Arterial thrombosis (HP:0004420) | 2.68516866 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65173789 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65173789 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 2.62995667 |
| 34 | Inflammation of the large intestine (HP:0002037) | 2.62120000 |
| 35 | Periodontitis (HP:0000704) | 2.58948491 |
| 36 | Gingival bleeding (HP:0000225) | 2.57346328 |
| 37 | Stomach cancer (HP:0012126) | 2.57036889 |
| 38 | Meningitis (HP:0001287) | 2.56706554 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.55133513 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.54455110 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.54455110 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.54455110 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.53043907 |
| 44 | Vasculitis (HP:0002633) | 2.52866184 |
| 45 | Spondylolisthesis (HP:0003302) | 2.52780231 |
| 46 | Impaired platelet aggregation (HP:0003540) | 2.52587586 |
| 47 | Abnormal platelet function (HP:0011869) | 2.52587586 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51621364 |
| 49 | Spinal cord lesions (HP:0100561) | 2.50987620 |
| 50 | Syringomyelia (HP:0003396) | 2.50987620 |
| 51 | Abnormality of T cells (HP:0002843) | 2.50639029 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.49859350 |
| 53 | Abnormal platelet volume (HP:0011876) | 2.49408931 |
| 54 | B lymphocytopenia (HP:0010976) | 2.48844301 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.48783121 |
| 56 | Acute lymphatic leukemia (HP:0006721) | 2.45073194 |
| 57 | Epistaxis (HP:0000421) | 2.44880527 |
| 58 | Increased IgE level (HP:0003212) | 2.41616234 |
| 59 | Nasal polyposis (HP:0100582) | 2.41551230 |
| 60 | Obstructive lung disease (HP:0006536) | 2.40581495 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40581495 |
| 62 | Dysostosis multiplex (HP:0000943) | 2.39821192 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.37584830 |
| 64 | Alveolar cell carcinoma (HP:0006519) | 2.35950894 |
| 65 | Abnormality of T cell number (HP:0011839) | 2.35646852 |
| 66 | Hypochromic anemia (HP:0001931) | 2.35506439 |
| 67 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.35413204 |
| 68 | Viral hepatitis (HP:0006562) | 2.35285079 |
| 69 | * Acute myeloid leukemia (HP:0004808) | 2.33956379 |
| 70 | Abnormality of macrophages (HP:0004311) | 2.33452583 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.32880829 |
| 72 | Colitis (HP:0002583) | 2.32481395 |
| 73 | Chest pain (HP:0100749) | 2.31080344 |
| 74 | Chronic diarrhea (HP:0002028) | 2.27642379 |
| 75 | Hypergammaglobulinemia (HP:0010702) | 2.25044502 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.22863342 |
| 77 | Amaurosis fugax (HP:0100576) | 2.21115212 |
| 78 | Cheilitis (HP:0100825) | 2.20382990 |
| 79 | Myelodysplasia (HP:0002863) | 2.20036885 |
| 80 | Episodic fever (HP:0001954) | 2.18807325 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.15935292 |
| 82 | Pulmonary embolism (HP:0002204) | 2.15692106 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 2.15163764 |
| 84 | Reticulocytopenia (HP:0001896) | 2.14362542 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13987608 |
| 86 | Abnormal number of erythroid precursors (HP:0012131) | 2.13403291 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.13094807 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 2.12825775 |
| 89 | Recurrent sinusitis (HP:0011108) | 2.11531938 |
| 90 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.10393236 |
| 91 | Increased mean platelet volume (HP:0011877) | 2.10341817 |
| 92 | Volvulus (HP:0002580) | 2.10271519 |
| 93 | IgG deficiency (HP:0004315) | 2.08928340 |
| 94 | T lymphocytopenia (HP:0005403) | 2.08664958 |
| 95 | Gastrointestinal stroma tumor (HP:0100723) | 2.08442897 |
| 96 | Leukocytosis (HP:0001974) | 2.08357166 |
| 97 | Pulmonary infiltrates (HP:0002113) | 2.07964325 |
| 98 | Abnormality of eosinophils (HP:0001879) | 2.05123724 |
| 99 | Gingivitis (HP:0000230) | 2.04000813 |
| 100 | Abnormality of male internal genitalia (HP:0000022) | 2.03412893 |
| 101 | Restrictive lung disease (HP:0002091) | 2.03085426 |
| 102 | Increased CSF protein (HP:0002922) | 2.02142096 |
| 103 | Hemoptysis (HP:0002105) | 2.01907584 |
| 104 | Encephalitis (HP:0002383) | 2.01875893 |
| 105 | Hematochezia (HP:0002573) | 2.01159296 |
| 106 | Gangrene (HP:0100758) | 2.00453500 |
| 107 | Granulocytopenia (HP:0001913) | 1.97291058 |
| 108 | Abnormality of the pleura (HP:0002103) | 1.97243523 |
| 109 | Skin ulcer (HP:0200042) | 1.96714203 |
| 110 | Facial diplegia (HP:0001349) | 1.96358739 |
| 111 | Osteomyelitis (HP:0002754) | 1.96163601 |
| 112 | Prostate neoplasm (HP:0100787) | 1.95126667 |
| 113 | Osteolytic defects of the hand bones (HP:0009699) | 1.94728529 |
| 114 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94728529 |
| 115 | Papilloma (HP:0012740) | 1.94444074 |
| 116 | Verrucae (HP:0200043) | 1.94444074 |
| 117 | Polygenic inheritance (HP:0010982) | 1.94389926 |
| 118 | Urticaria (HP:0001025) | 1.93816859 |
| 119 | Lymphoma (HP:0002665) | 1.93451506 |
| 120 | Aplastic anemia (HP:0001915) | 1.93442967 |
| 121 | Thyroiditis (HP:0100646) | 1.93435365 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.92278569 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92278569 |
| 124 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91246451 |
| 125 | Gastrointestinal infarctions (HP:0005244) | 1.89837041 |
| 126 | Eosinophilia (HP:0001880) | 1.88813916 |
| 127 | Chromsome breakage (HP:0040012) | 1.88185798 |
| 128 | Menorrhagia (HP:0000132) | 1.84676949 |
| 129 | Lymphopenia (HP:0001888) | 1.81721172 |
| 130 | Vacuolated lymphocytes (HP:0001922) | 1.79973857 |
| 131 | Fatigue (HP:0012378) | 1.78855556 |
| 132 | Purpura (HP:0000979) | 1.74605868 |
| 133 | Recurrent lower respiratory tract infections (HP:0002783) | 1.70796296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 2.84010852 |
| 2 | EEF2K | 2.78392074 |
| 3 | JAK3 | 2.61493457 |
| 4 | MATK | 2.42857479 |
| 5 | KIT | 2.33675779 |
| 6 | MST4 | 2.30409991 |
| 7 | IRAK4 | 2.27977898 |
| 8 | MAP3K14 | 2.24894210 |
| 9 | PIM2 | 2.21100509 |
| 10 | FRK | 2.15902782 |
| 11 | BTK | 2.10186539 |
| 12 | TYK2 | 1.97253021 |
| 13 | TBK1 | 1.84249284 |
| 14 | IKBKB | 1.81781836 |
| 15 | SIK3 | 1.80250719 |
| 16 | PIM1 | 1.78609265 |
| 17 | EPHB1 | 1.75578961 |
| 18 | TNK2 | 1.74746901 |
| 19 | FLT3 | 1.74525447 |
| 20 | BMPR2 | 1.71474311 |
| 21 | IRAK1 | 1.65669408 |
| 22 | BLK | 1.64787619 |
| 23 | MAP3K3 | 1.63725788 |
| 24 | MAP3K6 | 1.63525881 |
| 25 | RPS6KB2 | 1.61052993 |
| 26 | TAOK3 | 1.60544494 |
| 27 | TXK | 1.50635888 |
| 28 | IKBKE | 1.50382570 |
| 29 | CSK | 1.49158978 |
| 30 | TEC | 1.48660668 |
| 31 | TRPM7 | 1.46056075 |
| 32 | CDK6 | 1.45614441 |
| 33 | MAP3K10 | 1.43116818 |
| 34 | ERN1 | 1.42293849 |
| 35 | NUAK1 | 1.41091495 |
| 36 | MAPK15 | 1.39823953 |
| 37 | MAP2K3 | 1.39747087 |
| 38 | CHUK | 1.37271353 |
| 39 | ZAP70 | 1.36989594 |
| 40 | CSF1R | 1.36401486 |
| 41 | PRPF4B | 1.32849839 |
| 42 | RPS6KA4 | 1.30156144 |
| 43 | IRAK3 | 1.27161730 |
| 44 | STK10 | 1.26864807 |
| 45 | MAP3K11 | 1.23628278 |
| 46 | PKN2 | 1.23385519 |
| 47 | TGFBR1 | 1.21985230 |
| 48 | CDK7 | 1.21729530 |
| 49 | BMX | 1.21399432 |
| 50 | ICK | 1.20321719 |
| 51 | TRIB3 | 1.19675868 |
| 52 | FGFR3 | 1.17863596 |
| 53 | NME2 | 1.12995033 |
| 54 | NEK2 | 1.08760192 |
| 55 | FGFR4 | 1.07915967 |
| 56 | EPHA3 | 1.06576223 |
| 57 | PIK3CG | 1.05844791 |
| 58 | SYK | 1.05578981 |
| 59 | YES1 | 1.04324356 |
| 60 | LRRK2 | 1.03623489 |
| 61 | CDK12 | 1.03040842 |
| 62 | JAK1 | 1.01936977 |
| 63 | TGFBR2 | 1.00072510 |
| 64 | STK4 | 0.99945983 |
| 65 | LCK | 0.98395951 |
| 66 | CDC7 | 0.97372075 |
| 67 | WEE1 | 0.95485645 |
| 68 | LYN | 0.94980286 |
| 69 | ATR | 0.93716316 |
| 70 | CDK4 | 0.92571896 |
| 71 | JAK2 | 0.88925340 |
| 72 | PAK4 | 0.87261646 |
| 73 | PTK6 | 0.86487056 |
| 74 | GRK7 | 0.85710927 |
| 75 | MAPKAPK3 | 0.85380550 |
| 76 | MAP4K2 | 0.85314997 |
| 77 | STK24 | 0.84503645 |
| 78 | MAP3K1 | 0.84487125 |
| 79 | ADRBK2 | 0.84013375 |
| 80 | HCK | 0.82992303 |
| 81 | RIPK4 | 0.82865882 |
| 82 | DDR2 | 0.81817205 |
| 83 | RPS6KA6 | 0.78716623 |
| 84 | PRKCQ | 0.78175497 |
| 85 | HIPK2 | 0.77631245 |
| 86 | STK3 | 0.76526114 |
| 87 | CDC42BPA | 0.74033216 |
| 88 | DYRK1B | 0.73440415 |
| 89 | BRSK2 | 0.72235232 |
| 90 | EIF2AK3 | 0.71780179 |
| 91 | DAPK1 | 0.71003875 |
| 92 | RPS6KL1 | 0.70785091 |
| 93 | RPS6KC1 | 0.70785091 |
| 94 | MKNK1 | 0.69738567 |
| 95 | MAPK11 | 0.67504173 |
| 96 | NLK | 0.67107977 |
| 97 | MARK3 | 0.66733135 |
| 98 | MAPK7 | 0.65690997 |
| 99 | MAPKAPK2 | 0.64741224 |
| 100 | TAOK1 | 0.62756894 |
| 101 | MAP3K8 | 0.61760650 |
| 102 | DYRK3 | 0.60957189 |
| 103 | ITK | 0.60022418 |
| 104 | ACVR1B | 0.60021989 |
| 105 | PTK2B | 0.59668488 |
| 106 | CLK1 | 0.59355204 |
| 107 | NEK9 | 0.55375063 |
| 108 | CDK9 | 0.54795142 |
| 109 | MAP2K6 | 0.53712080 |
| 110 | FGR | 0.53420286 |
| 111 | ABL1 | 0.53262555 |
| 112 | MAP3K13 | 0.53240769 |
| 113 | PDK1 | 0.53007840 |
| 114 | GRK6 | 0.51158178 |
| 115 | PRKD2 | 0.49235256 |
| 116 | FER | 0.48261076 |
| 117 | BRD4 | 0.47574384 |
| 118 | RPS6KA1 | 0.46667648 |
| 119 | EGFR | 0.45643183 |
| 120 | ALK | 0.45381330 |
| 121 | MAPK4 | 0.44871101 |
| 122 | TIE1 | 0.43458354 |
| 123 | RIPK1 | 0.42395723 |
| 124 | GSK3A | 0.42351339 |
| 125 | DAPK2 | 0.42094569 |
| 126 | SGK3 | 0.41449346 |
| 127 | IRAK2 | 0.40900298 |
| 128 | MAP3K2 | 0.40360580 |
| 129 | FES | 0.39161401 |
| 130 | MKNK2 | 0.39011149 |
| 131 | AURKB | 0.38867982 |
| 132 | RAF1 | 0.38705254 |
| 133 | MELK | 0.34743917 |
| 134 | MAP3K5 | 0.34232969 |
| 135 | * MAPK3 | 0.31788046 |
| 136 | SGK2 | 0.31428509 |
| 137 | IGF1R | 0.26923385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 2.91645277 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.60942843 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.38363354 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 2.23697891 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15237493 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.12189414 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.10921545 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.01564447 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.96769891 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92732489 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88428843 |
| 12 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.83682262 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77163233 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75966458 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72823704 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72651350 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69780319 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69448721 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.57968763 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.57204984 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.57139133 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57066657 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.54238279 |
| 24 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.51572563 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.48103857 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47061725 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44308778 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.42682944 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41057980 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.41017442 |
| 31 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.39481306 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.36640486 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.33055076 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.28254261 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.28161465 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.27746829 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26187880 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.26046104 |
| 39 | Cell cycle_Homo sapiens_hsa04110 | 1.20682463 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.20481543 |
| 41 | Spliceosome_Homo sapiens_hsa03040 | 1.20374184 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15444362 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14815763 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13855656 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.11329793 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10527345 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08642034 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07622551 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06184216 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05446932 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03547537 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03512807 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.99012750 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98267931 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97472403 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.96490858 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.95859821 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.95743295 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94702234 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93643178 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92955905 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.90342221 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.89926518 |
| 64 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87725069 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85492156 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84763471 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.84056143 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83916511 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83247138 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83099048 |
| 71 | RNA transport_Homo sapiens_hsa03013 | 0.83057607 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79956378 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78918346 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78426261 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76824153 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.75434810 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74943617 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74128633 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72616044 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69931903 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67550064 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64256518 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.63746236 |
| 84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61487300 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59660618 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59234039 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.56102510 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55715800 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55512477 |
| 90 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.55423593 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55401883 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53044637 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52680150 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51102735 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50140680 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.49003339 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48436267 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.47705022 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47306356 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46898050 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46338407 |
| 102 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45774628 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45313713 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44934850 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42077049 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41957513 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41418778 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39947750 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39919960 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39718126 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.39093545 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38919990 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38346616 |
| 114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38055343 |
| 115 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37393299 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37366767 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35567605 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34568584 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34043770 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.33950765 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33612652 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32818725 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32527928 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32464864 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32151352 |
| 126 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32116533 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28562056 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28510793 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28449014 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25235038 |
| 131 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24412170 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22830093 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.21824888 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.21712291 |

